Vivos Sistema de Cirurgia Oftàlmica de Olcayto Guelec and David Geuder

El disseny Vivos Sistema de Cirurgia Oftàlmica de Olcayto Guelec and David Geuder és un guanyador molt estimat del prestigiós 2026 A' Design Award d'Or en la Categoria de Competició de Disseny de Dispositius Mèdics i Equipament Mèdic.

OrProducte Mèdic· 2026

Vivos Sistema de Cirurgia Oftàlmica

de Olcayto Guelec and David Geuder

Client: Geuder AG

Guanyador del A' Design Award d'Or en la Categoria de Producte Mèdic

56,783

Guanyador de Premi Verificat

Verificar l'Estat del Premi per al #182492

Veure a A' Design Award Nota de Premsa Insígnia del Premi

Colors

El Disseny

Sobre Vivos Sistema de Cirurgia Oftàlmica

Vivos redefineix l'estació de treball quirúrgica com una plataforma que evoluciona al costat de l'ambició clínica. Tres configuracions, Core, Nova i Nova+, amplien les capacitats sense necessitat de substituir el sistema, l'única arquitectura d'actualització d'aquest tipus en la cirurgia oftàlmica. Una interfície única, validada amb un 91,7 per cent de satisfacció en el primer ús sense formació prèvia, reflecteix un disseny concebut al voltant del cirurgià més que del procediment. Les connexions il·luminades dels instruments, els materials refinats i els detalls sobris confereixen al dispositiu una presència serena i segura, lliure del soroll visual característic de la categoria.

El Reconeixement

Sobre el A' Design Award d'Or

Vivos Sistema de Cirurgia Oftàlmica és un guanyador del guardó A' Design Award d'Or, un reconeixement immensament prestigiós concedit a dissenys de primera categoria, meravellosos i extraordinaris. Els guanyadors d'Or són creacions summament innovadores, molt visionàries i gloriosament enlluernadores que reflecteixen el prodigi, la saviesa i la destresa dels seus dissenyadors. Es preveu que Vivos Sistema de Cirurgia Oftàlmica sigui un invent molt elogiat, pioner en tendències i monumental, que aporta un valor sense precedents. Aquest disseny guanyador del guardó A' Design Award d'Or és un projecte espectacular i respectat que beneficia molt i fa avançar els límits de l'art, la ciència, el disseny i la tecnologia. Vivos Sistema de Cirurgia Oftàlmica crea sentiments intensos de desig, evoca passió, fomenta la creativitat i ens fascina.

Darrere del Disseny

Dossier de Premsa

Crèdits, membres de l'equip i detalls tècnics proporcionats pel dissenyador.

Propietats Úniques: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensions i Embalatge: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Etiquetes: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tecnologia de Producció: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Repte de Disseny: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Recerca: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiració: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Durada del Projecte: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Flux d'Operació: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Membres de l'Equip: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Crèdits de les Imatges: Photography Geuder AG, 2026